Aurinia Pharmaceuticals Inc. (AUPH) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 480.24M | 491.97M | 438.74M | 408.97M | 405.76M | 446.6M | 440.46M | 409.67M | 398.22M | 424.8M | 426.47M | 415.91M |
| Cash & Short-Term Investments | 378.78M | 398M | 351.81M | 315.13M | 312.9M | 358.48M | 348.75M | 330.48M | 319.91M | 350.49M | 337.9M | 350.71M |
| Cash Only | 41.01M | 80.21M | 73.19M | 53M | 66.43M | 83.43M | 37.14M | 33.41M | 64.46M | 48.88M | 46.4M | 81.71M |
| Short-Term Investments | 337.77M | 317.78M | 278.62M | 262.13M | 246.47M | 275.04M | 311.61M | 297.07M | 255.45M | 301.61M | 291.5M | 269.01M |
| Accounts Receivable | 49.17M | 41.45M | 30.93M | 40.09M | 40.35M | 36.54M | 36.48M | 25.52M | 28.91M | 24.09M | 37.95M | 19.5M |
| Days Sales Outstanding | 52.48 | 43.18 | 44.47 | 52.28 | 55.39 | 56.11 | 42.09 | 43.3 | 47.94 | 63.28 | 48.47 | 42.27 |
| Inventory | 46.41M | 45.69M | 44.79M | 46.5M | 46.2M | 39.23M | 38.71M | 38.85M | 39.76M | 39.7M | 32.82M | 33.16M |
| Days Inventory Outstanding | 637.13 | 491.29 | 493.84 | 592.8 | 448.34 | 645.77 | 591.23 | 401.5 | 466.42 | 618.38 | 448.35 | 1.89K |
| Other Current Assets | 5.88M | 6.83M | 101K | 665K | 781K | 1.13M | 16.52M | 6.98M | 2M | 1.03M | 1.65M | 1.21M |
| Total Non-Current Assets | 243.75M | 259.62M | 88.79M | 93.59M | 99.09M | 104.05M | 108.9M | 113.86M | 118.41M | 123.26M | 128.54M | 132.99M |
| Property, Plant & Equipment | 73.15M | 79.57M | 84.8M | 89.45M | 94.11M | 98.87M | 103.53M | 108.18M | 111.95M | 116.57M | 121.17M | 125.79M |
| Fixed Asset Turnover | 1.02x | 0.94x | 0.84x | 0.76x | 0.65x | 0.59x | 0.64x | 0.52x | 0.44x | 0.38x | 0.44x | 0.62x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.59M | 3.76M | 3.9M | 4.05M | 4.16M | 4.36M | 4.51M | 4.62M | 4.76M | 4.98M | 5.26M | 5.68M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 199K | 199K | 201K | 591K | 0 |
| Other Non-Current Assets | 93K | 93K | 93K | 93K | 823K | 823K | 868K | 867K | 1.5M | 1.52M | 1.52M | 1.52M |
| Total Assets | 724M | 751.59M | 527.53M | 502.56M | 504.85M | 550.64M | 549.36M | 523.53M | 516.63M | 548.06M | 555.01M | 548.9M |
| Asset Turnover | 0.11x | 0.12x | 0.14x | 0.14x | 0.12x | 0.11x | 0.13x | 0.11x | 0.09x | 0.08x | 0.10x | 0.08x |
| Asset Growth % | 43.41% | 36.49% | -3.97% | -4% | -2.28% | 0.47% | -1.02% | -4.62% | 14.36% | 16.4% | 13.66% | 13.84% |
| Total Current Liabilities | 86.56M | 93.72M | 76.22M | 78.27M | 68.41M | 97.76M | 78.61M | 76.9M | 71.05M | 77.19M | 73.89M | 61.66M |
| Accounts Payable | 2.66M | 3.31M | 2.21M | 3.31M | 4.22M | 5.19M | 8.88M | 8.41M | 5.67M | 4.33M | 8.85M | 4.81M |
| Days Payables Outstanding | 41.33 | 30.01 | 29.89 | 48.17 | 49.37 | 116.53 | 131.81 | 71.95 | 58.69 | 112.39 | 92.84 | 247.09 |
| Short-Term Debt | 18.14M | 17.59M | 17.37M | 0 | 0 | 15.07M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 5.04M | 3.72M | 4.6M | 5.5M | 4.59M | 11M | 4.3M | 4.37M | 4.91M | 4.81M | 4.66M | 3.23M |
| Other Current Liabilities | 59.17M | 69.1M | 42.27M | 2.54M | 1.7M | 66.5M | 790K | 1.16M | 32.93M | 1.59M | 2.61M | 2.09M |
| Current Ratio | 5.55x | 5.25x | 5.76x | 5.23x | 5.93x | 4.57x | 5.60x | 5.33x | 5.60x | 5.50x | 5.77x | 6.75x |
| Quick Ratio | 5.01x | 4.76x | 5.17x | 4.63x | 5.26x | 4.17x | 5.11x | 4.82x | 5.05x | 4.99x | 5.33x | 6.21x |
| Cash Conversion Cycle | 648.28 | 504.46 | 508.42 | 596.91 | 454.36 | 585.35 | 501.51 | 372.86 | 455.67 | 569.27 | 403.98 | 1.68K |
| Total Non-Current Liabilities | 69.81M | 76.53M | 85.54M | 89M | 86.25M | 75.4M | 82.75M | 82.01M | 86.11M | 92.92M | 89.25M | 94.95M |
| Long-Term Debt | 50.5M | 57.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 60.85M | 64.62M | 62.37M | 64.3M | 71.91M | 71.07M | 73.81M | 82.01M | 78.91M | 86.24M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 19.32M | 19.31M | 12.44M | 12.03M | 11.44M | 11.11M | 10.84M | 10.94M | 12.29M | 10.91M | 10.34M | 8.71M |
| Total Liabilities | 156.37M | 170.26M | 161.76M | 167.26M | 154.66M | 173.17M | 161.36M | 158.91M | 157.16M | 170.11M | 163.14M | 156.61M |
| Total Debt | 68.64M | 74.81M | 78.21M | 81.83M | 77.91M | 79.37M | 87.85M | 85.98M | 88.54M | 97.61M | 93.21M | 101.21M |
| Net Debt | 27.63M | -5.4M | 5.02M | 28.83M | 11.48M | -4.06M | 50.71M | 52.58M | 24.08M | 48.73M | 46.82M | 19.5M |
| Debt / Equity | 0.12x | 0.13x | 0.21x | 0.24x | 0.22x | 0.21x | 0.23x | 0.24x | 0.25x | 0.26x | 0.24x | 0.26x |
| Debt / EBITDA | 1.48x | 1.96x | 2.26x | 3.28x | 2.92x | 24.86x | 5.28x | 25.82x | - | - | - | - |
| Net Debt / EBITDA | 0.60x | -0.14x | 0.15x | 1.16x | 0.43x | -1.27x | 3.05x | 15.79x | - | - | - | - |
| Interest Coverage | 44.40x | 6.48x | - | 20.84x | 23.82x | 2.02x | 13.26x | 2.23x | -6.80x | -19.16x | -8.39x | -185.68x |
| Total Equity | 567.63M | 581.33M | 365.77M | 335.3M | 350.19M | 377.48M | 388M | 364.62M | 359.48M | 377.95M | 391.88M | 392.29M |
| Equity Growth % | 62.09% | 54% | -5.73% | -8.04% | -2.58% | -0.13% | -0.99% | -7.05% | -7.92% | -6.78% | -7.45% | -7.43% |
| Book Value per Share | 4.12 | 4.19 | 2.69 | 2.34 | 2.52 | 2.56 | 2.66 | 2.53 | 2.50 | 2.63 | 2.74 | 2.75 |
| Total Shareholders' Equity | 567.63M | 581.33M | 365.77M | 335.3M | 350.19M | 377.48M | 388M | 364.62M | 359.48M | 377.95M | 391.88M | 392.29M |
| Common Stock | 1.09B | 1.12B | 1.12B | 1.12B | 1.16B | 1.19B | 1.21B | 1.21B | 1.21B | 1.2B | 1.2B | 1.2B |
| Retained Earnings | -615.01M | -649.37M | -860.16M | -891.71M | -913.23M | -936.57M | -938M | -952.35M | -953.07M | -942.32M | -915.45M | -902M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -880K | -599K | -749K | -905K | -825K | -647K | -385K | -859K | -854K | -730K | -947K | -1.02M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |